Skip to contents
In This Issue:
For the ninth year in a row, BWH ranked second in research funding from the National Institutes of Health (NIH) among independent hospitals, up 15.5 percent from last year. In 2002, BWH received more than $205 million dollars in funding from the NIH. The Boston medical community led the nation, boasting the number one through five top-funded independent hospitals. Among independent hospitals, Massachusetts General Hospital ranked first in funding with more than $243 million and Beth Israel Deaconess, with more than $99 million, ranked third. Dana-Farber Cancer Institute and Children’s Hospital Boston ranked fourth and fifth, respectively.
“The 15 percent growth in NIH research funding we have experienced this year is truly remarkable,” said Keith Marcotte, vice president, BWH Research. “With the new Harvard and Children’s research buildings scheduled to open their doors this fall, we anticipate continued growth as it relates to the new space. In addition, the newly created Executive Committee on Research Space is currently in the process of making recommendations on the best uses of the backfill space created by the move to each of these new facilities. This acquisition of space will allow for new research projects to move forward and for new multi-disciplinary, multi-departmental programs to come to fruition.”
Partners HeathCare again represented a strong showing, receiving a more than $474 million in combined NIH funding. This total brings Partners HealthCare second only to Johns Hopkins among all institutions receiving funds.
In 2002, BWH’s total research expenditures, including federal and non-federal funds as well as direct and indirect costs, reached more than $287 million, and it is anticipated that expenditures will exceed $321 million this year. Partners as a whole spends more than $686 million on research, making it one of the largest bio-medical research institutions in the world.